TY - CONF T1 - Cost-effectiveness of bosentan versus epoprostenol and no active treatment when added to palliative care for UK patients with pulmonary arterial hypertension of WHO functional class III JO - EUROPEAN HEART JOURNAL PY - 2008/09/01 AU - Stevenson MD AU - Macdonald FC AU - Langley J AU - Akehurst RL ED - VL - 29 SP - 859 EP - 859 Y2 - 2025/06/24 ER -